Microbiological and serological diagnosis of Lyme borreliosis

FEMS Immunology and Medical Microbiology

Volumn 49, Issue 1, 2007, Pages 13-21

  Wilske, Bettina ^a   Fingerle, Volker ^a   Schulte Spechtel, Ulrike ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Borrelia; Immunoblot; Lyme borreliosis; Microbiological diagnosis; PCR; Serological diagnosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBODY DETECTION; BACTERIUM CULTURE; BODY FLUID; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CELL LYSATE; CEREBROSPINAL FLUID; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; HUMAN; IMMUNOBLOTTING; IN VIVO STUDY; LYME DISEASE; LYMPHOCYTE TRANSFORMATION TEST; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SERUM; SHORT SURVEY; SKIN BIOPSY; SYNOVIAL FLUID; SYNOVIUM; URINE;

BORRELIA; HUMANS; LYME DISEASE;

EID: 33846502033     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00139.x     Document Type: Short Survey

References (80)

1. Arnez M, Ruzic-Sabljic E, Ahcan J, Radsel-Medvescek A, Pleterski-Rigler D & Strle F (2001) Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans. Pediatr Infect Dis J 20: 251-255.
2. Asbrink E & Olsson I (1985) Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. A comparison with Lyme disease. Acta Derm Venereol 65: 43-52.
3. Asbrink E, Hovmark A & Hederstedt B (1985) Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays. Acta Derm Venereol 65: 509-514.
4. Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD Jr, Philipp MT, Steere AC, Wormser GP, Marques AR & Johnson BJ (2003) Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 187: 1187-1199.
5. Brettschneider S, Bruckbauer H, Klugbauer N & Hofmann H (1998) Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 36: 2658-2665.
6. Brouqui P, Bacellar F, Baranton G et al. (2004) Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 10: 1108-1132.
7. Buechner SA, Lautenschlager S, Itin P, Bircher A & Erb P (1995) Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Arch Dermatol 131: 673-677.
8. Canica MM, Nato F, Du ML, Mazie JC, Baranton G & Postic D (1993) Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis 25: 441-448.
9. Centers for Disease Control and Prevention (1995) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb Mortal Wkly Rep 44: 590.
10. Christen HJ, Hanefeld F, Eiffert H & Thomssen R (1993) Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr 386 Suppl, 1-75.
11. Coyle PK, Schutzer SE, Belman AL, Krupp LB & Dheng Z (1992) Cerebrospinal fluid immunologic parameters in neurologic Lyme disease. Lyme Disease: Molecular and Immunologic Approaches (Schutzer S.E., ed), pp. 31-44. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
12. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J & Golightly MG (1988) Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 319: 1441-1446.
13. Demaerschalck I, Ben Messaoud A, De Kesel M, Hoyois B, Lobet Y, Hoet P, Bigaignon G, Bollen A & Godfroid E (1995) Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol 33: 602-608.
14. Department of Health and Human Services, C.f.D.C.a.P. (2005) Caution regarding testing for Lyme disease. Morb Mortal Wkly Rep 54: 125.
15. Dressler F, Ackermann R & Steere AC (1994) Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis. J Infect Dis 169: 313-318.
16. Dumler JS (2003) Molecular methods for ehrlichiosis and Lyme disease. Clin Lab Med 23: 867-884, vi.
17. Eiffert H, Ohlenbusch A, Christen HJ, Thomssen R, Spielman A & Matuschka FR (1995) Nondifferentiation between Lyme disease spirochetes from vector ticks and human cerebrospinal fluid. J Infect Dis 171: 476-479.
18. Eiffert H, Karsten A, Thomssen R & Christen HJ (1998) Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis 30: 265-268.
19. Gern L, Hu CM, Kocianova E, Vyrostekova V & Rehacek J (1999) Genetic diversity of Borrelia burgdorferi sensu lato isolates obtained from Ixodes ricinus ticks collected in Slovakia. Eur J Epidemiol 15: 665-669.
20. Goettner G, Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B & Fingerle V (2005) Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J Clin Microbiol 43: 3602-3609.
21. Hansen K & Asbrink E (1989) Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. J Clin Microbiol 27: 545-551.
22. Hansen K & Lebech AM (1991) Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi- specific immunoglobulin G, A, and M. Ann Neurol 30: 197-205.
23. Hansen K, Hindersson P & Pedersen NS (1988) Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol 26: 338-346.
24. Hansen K, Cruz M & Link H (1990) Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 161: 1194-1202.
25. Hauser U, Lehnert G, Lobentanzer R & Wilske B (1997) Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 35: 1433-1444.
26. Hauser U, Lehnert G & Wilske B (1998) Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe. Clin Diagn Lab Immunol 5: 456-462.
27. Heikkila T, Seppala I, Saxen H, Panelius J, Yrjanainen H & Lahdenne P (2002) Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein. Am J Clin Microbiol 40: 453-460.
28. Horowitz HW, Pavia CS, Bittker S, Forseter G, Cooper D, Nadelman RB, Byrne D, Johnson RC & Wormser GP (1994) Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology. Clin Diagn Lab Immunol 1: 373-378.
29. Hubalek Z & Halouzka J (1997) Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Eur J Epidemiol 13: 951-957.
30. Hyde FW, Johnson RC, White TJ & Shelburne CE (1989) Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol 27: 58-61.
31. Jaulhac B, Chary-Valckenaere I, Sibilia J, Javier RM, Piemont Y, Kuntz JL, Monteil H & Pourel J (1996) Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum 39: 736-745.
32. Jaulhac B, Heller R, Limbach FX, Hansmann Y, Lipsker D, Monteil H, Sibilia J & Piemont Y (2000) Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with Lyme arthritis. J Clin Microbiol 38: 1895-1900.
33. Johnson BJ, Robbins KE, Bailey RE, Cao BL, Sviat SL, Craven RB, Mayer LW & Dennis DT (1996) Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis 174: 346-353.
34. Kaiser R (1998) Prevention of early summer meningoencephalitis and Lyme borreliosis before and after tick bites. Dtsch Med Wochenschr 123: 847-853.
35. Kalish RS, Wood JA, Golde W, Bernard R, Davis LE, Grimson RC, Coyle PK & Luft BJ (2003) Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function, antigen type 1 peptide response and clinical status. J Infect Dis 187: 102-108.
36. Karch H, Huppertz HI, Bohme M, Schmidt H, Wiebecke D & Schwarzkopf A (1994) Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies. J Clin Microbiol 32: 2312-2314.
37. Karlsson M, Hovind-Hougen K, Svenungsson B & Stiernstedt G (1990) Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 28: 473-479.
38. Klempner MS, Schmid CH, Hu L, Steere AC, Johnson G, McCloud B, Noring R & Weinstein A (2001) Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med 110: 217-219.
39. Kristoferitsch W (1993) Neurologic manifestations in Lyme borreliosis. Clin Dermatol 11: 393-400.
40. Lawrenz MB, Hardham JM, Owens RT, Nowakowski J, Steere AC, Wormser GP & Norris SJ (1999) Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 37: 3997-4004.
41. Lebech AM, Hansen K, Brandrup F, Clemmensen O & Halkier-Sorensen L (2000) Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn 5: 139-150.
42. Liang FT & Philipp MT (1999) Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi. Infect Immun 67: 6702-6706.
43. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN & Philipp MT (1999) Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol 37: 3990-3996.
44. Liang FT, Aberer E, Cinco M, Gern L, Hu CM, Lobet YN, Ruscio M, Voet PE Jr, Weynants VE & Philipp MT (2000) Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J Infect Dis 182: 1455-1462.
45. Lunemann JD, Zarmas S, Priem S et al. (2001) Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis. J Clin Microbiol 39: 1130-1133.
46. Michel H, Wilske B, Hettche G, Goettner G, Heimerl C, Reischl U, Schulte-Spechtel U & Fingerle V (2003) An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types. Med Microbiol Immunol (Berlin) 193: 219-226.
47. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH & Steere AC (1994) Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 330: 229-234.
48. Ohlenbusch A, Matuschka FR, Richter D, Christen HJ, Thomssen R, Spielman A & Eiffert H (1996) Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis 174: 421-423.
49. Panelius J, Lahdenne P, Saxen H, Carlsson SA, Heikkila T, Peltomaa M, Lauhio A & Seppala I (2003) Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide. J Neurol 250: 1318-1327.
50. Peter O, Bretz AG & Bee D (1995) Occurrence of different genospecies of Borrelia burgdorferi sensu lato in ixodid ticks of Valais, Switzerland. Eur J Epidemiol 11: 463-467.
51. Pfister HW, Wilske B & Weber K (1994) Lyme borreliosis: basic science and clinical aspects. Lancet 343: 1013-1016.
52. Preac-Mursic V, Wilske B & Reinhardt S (1991) Culture of Borrelia burgdorferi on six solid media. Eur J Clin Microbiol Infect Dis 10: 1076-1079.
53. Rauter C, Oehme R, Diterich I, Engele M & Hartung T (2002) Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR. J Clin Microbiol 40: 36-43.
54. Richter D, Postic D, Sertour N, Livey I, Matuschka F-R & Baranton G (2006) Delineation of Borrelia burgdorferi sensu lato species by multilocus sequence analysis and confirmation of the delineation of B. spielmanii sp. nov. Int J Syst Evol Microbiol 56: 873-881.
55. Rijpkema S, Golubic D, Molkenboer M, Verbeek-de Kruif N & Schellekens J (1996) Identification of four genomic groups of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks collected in a Lyme borreliosis endemic region of northern Croatia. Exp Appl Acarol 20: 23-30.
56. Rijpkema SG, Tazelaar DJ, Molkenboer MJ, Noordhoek GT, Plantinga G, Schouls LM & Schellekens JF (1997) Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronica atrophicans. Clin Microbiol Infect 3: 109-116.
57. Robertson J, Guy E & Andrews N (2000) A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 38: 2097-2102.
58. Schmidt BL (1997) PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 10: 185-201.
59. Schulte-Spechtel U, Lehnert G, Liegl G, Fingerle V, Heimerl C, Johnson BJ & Wilske B (2003) Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J Clin Microbiol 41: 1299-1303.
60. Schulte-Spechtel U, Fingerle V, Goettner G, Rogge S & Wilske B (2006) Molecular analysis of decorin-binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene. Int J Med Microbiol 296: 250-266.
61. Stanek G & Strle F (2003) Lyme borreliosis. Lancet 362: 1639-1647.
62. Stanek G, O'Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, Guy E & Gray J (1996) European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 108: 741-747.
63. Steere AC (1989) Lyme disease. N Engl J Med 321: 586-596.
64. Strle F (1999) Principles of the diagnosis and antibiotic treatment of Lyme borreliosis. Wien Klin Wochenschr 111: 911-915.
65. van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, Ramselaar AC, Kramer MD & Dankert J (1993) Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 17: 708-717.
66. Vasiliu V, Herzer P, Rössler D, Lehnert G & Wilske B (1998) Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA-type-specific PCR in synovial fluid from patients with Lyme arthritis. Med Microbiol Immunol (Berlin) 187: 97-102.
67. von Stedingk LV, Olsson I, Hanson HS, Asbrink E & Hovmark A (1995) Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur J Clin Microbiol Infect Dis 14: 1-5.
68. Wang G, van Dam AP & Dankert J (1999a) Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with Lyme borreliosis. J Clin Microbiol 37: 3025-3028.
69. Wang G, van Dam AP, Schwartz I & Dankert J (1999b) Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 12: 633-653.
70. Wilske B (2005) Epidemiology and diagnosis of Lyme borreliosis. Ann Med 37: 568-579.
71. Wilske B & Preac-Mursic V (1993) Microbiological diagnosis of Lyme borreliosis. Aspects of Lyme Borreliosis (Weber K & Burgdorfer W, eds), pp. 267-300. Springer Verlag, Berlin.
72. Wilske B & Schriefer M (2003) Borrelia. Manual of Clinical Microbiology (Murray PR, Baron EJ, Jorgensen JH, Pfaller MA & Yolken RH, eds), pp. 937-954. ASM Press, Washington, DC.
73. Wilske B, Schierz G, Preac-Mursic V, von Busch K, Kuhbeck R, Pfister HW & Einhäupl K (1986) Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis 153: 304-314.
74. Wilske B, Fingerle V, Herzer P, Hofmann A, Lehnert G, Peters H, Pfister HW, Preac-Mursic V, Soutschek E & Weber K (1993a) Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Med Microbiol Immunol (Berlin) 182: 255-270.
75. Wilske B, Preac-Mursic V, Göbel UB, Graf B, Jauris S, Soutschek E, Schwab E & Zumstein G (1993b) An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J Clin Microbiol 31: 340-350.
76. Wilske B, Busch U, Eiffert H, Fingerle V, Pfister HW, Rössler D & Preac-Mursic V (1996a) Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol (Berlin) 184: 195-201.
77. Wilske B, Busch U, Fingerle V, Jauris-Heipke S, Preac-Mursic V, Rössler D & Will G (1996b) Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection 24: 208-212.
78. Wilske B, Habermann C, Fingerle V, Hillenbrand B, Jauris-Heipke S, Lehnert G, Pradel I, Rössler D & Schulte-Spechtel U (1999) An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis. Med Microbiol Immunol (Berlin) 188: 139-144.
79. Wilske B, Zöller L, Brade V, Eiffert H, Göbel UB, Stanek G & Pfister HW (2000) MIQ 12, Lyme-Borreliose. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik (Mauch H & Lütticken R, eds), pp. 1-59. Urban & Fischer Verlag, Munich.
80. Zore A, Ruzic-Sabljic E, Maraspin V, Cimperman J, Lotric-Furlan S, Pikelj A, Jurca T, Logar M & Strle F (2002) Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wien Klin Wochenschr 114: 606-609.